Terms: = Head and neck cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
371 results:
1. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM
Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.
Hu X; Dong Y; Xie S; Song Y; Yu C; He Y; Wang Z; Hu Q; Ni Y; Ding L
J Pathol Clin Res; 2024 Mar; 10(2):e353. PubMed ID: 38502058
[TBL] [Abstract] [Full Text] [Related]
4. CD4+ foxp3+ Regulatory T-cells in Modulating Inflammatory Microenvironment in Chronic Rhinosinusitis with Nasal Polyps: Progress and Future Prospect.
M Yusoff NNF; Ahmad S; Wan Abdul Rahman WF; Mohamud R; C Boer J; Plebanski M; Abdullah B; Chen X; Tengku Din TADA
Cytokine; 2024 Jun; 178():156557. PubMed ID: 38452440
[TBL] [Abstract] [Full Text] [Related]
5. Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade.
Oh KY; Hong SD; Yoon HJ
J Oral Pathol Med; 2024 Mar; 53(3):217-225. PubMed ID: 38449350
[TBL] [Abstract] [Full Text] [Related]
6. Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb.
Zhang Z; Yang N; Lu H; Chen Y; Xu L; Wang Z; Lu Q; Zhong K; Zhu Z; Wang G; Li H; Zheng M; Zhang W; Yang H; Peng X; Zhou L; Tong A
Cancer Lett; 2024 Apr; 588():216760. PubMed ID: 38428724
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.
Zhu X; Heng Y; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
Hum Cell; 2024 May; 37(3):714-728. PubMed ID: 38358636
[TBL] [Abstract] [Full Text] [Related]
8. Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancers.
Baudouin R; Tartour E; Badoual C; Hans S
Mol Med; 2024 Feb; 30(1):26. PubMed ID: 38355394
[TBL] [Abstract] [Full Text] [Related]
9. Momordicine-I Suppresses head and neck cancer Growth by Reprogrammimg Immunosuppressive Effect of the Tumor-Infiltrating Macrophages and B Lymphocytes.
Sur S; Bhartiya P; Steele R; Brennan M; DiPaolo RJ; Ray RB
Mol Cancer Ther; 2024 May; 23(5):672-682. PubMed ID: 38315993
[TBL] [Abstract] [Full Text] [Related]
10. Spatial heterogeneity of tumor cells and the tissue microenvironment in oral squamous cell carcinoma.
Steffen C; Schallenberg S; Dernbach G; Dielmann A; Dragomir MP; Schweiger-Eisbacher C; Klauschen F; Horst D; Tinhofer I; Heiland M; Keilholz U
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; 137(4):379-390. PubMed ID: 38281880
[TBL] [Abstract] [Full Text] [Related]
11. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma.
Li S; Chen Z; Liu M; Li L; Cai W; Lian ZX; Guan H; Xu B
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38214937
[TBL] [Abstract] [Full Text] [Related]
12. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.
Gavrielatou N; Fortis E; Spathis A; Anastasiou M; Economopoulou P; Foukas GRP; Lelegiannis IM; Rusakiewicz S; Vathiotis I; Aung TN; Tissot S; Kastrinou A; Kotsantis I; Vagia EM; Panayiotides I; Rimm DL; Coukos G; Homicsko K; Foukas P; Psyrri A
Ann Oncol; 2024 Apr; 35(4):340-350. PubMed ID: 38159908
[TBL] [Abstract] [Full Text] [Related]
13. Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
Miraki Feriz A; Bahraini F; Khosrojerdi A; Azarkar S; Sajjadi SM; HosseiniGol E; Honardoost MA; Saghafi S; Silvestris N; Leone P; Safarpour H; Racanelli V
PLoS One; 2023; 18(12):e0295863. PubMed ID: 38096229
[TBL] [Abstract] [Full Text] [Related]
14. Circulating levels of foxp3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients.
Mokni Baizig N; Ben ElHadj M; Hsairi M; Fourati A; Kamoun S; Houcine Y; Gritli S; Driss M
J Immunoassay Immunochem; 2024 Mar; 45(2):79-92. PubMed ID: 37936281
[TBL] [Abstract] [Full Text] [Related]
15. Immune checkpoint analysis in ear cancer.
Klein M; Polgart E; Hallermann C; Schulze HJ; Hölzle F; Wermker K
Head Face Med; 2023 Nov; 19(1):48. PubMed ID: 37932810
[TBL] [Abstract] [Full Text] [Related]
16. Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events.
Tan J; Liang Y; Yang Z; He Q; Tong J; Deng Y; Guo W; Liang K; Tang J; Shi W; Yu B
Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):2312-2332. PubMed ID: 37881939
[TBL] [Abstract] [Full Text] [Related]
17. Role of tissue markers associated with tumor microenvironment in the progression and immune suppression of oral squamous cell carcinoma.
Ramalingam S; Shantha S; Muralitharan S; Sudhakar U; Thamizhchelvan H; Parvathi VD
Med Oncol; 2023 Sep; 40(10):303. PubMed ID: 37731058
[TBL] [Abstract] [Full Text] [Related]
18. PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Kawasaki K; Noma K; Kato T; Ohara T; Tanabe S; Takeda Y; Matsumoto H; Nishimura S; Kunitomo T; Akai M; Kobayashi T; Nishiwaki N; Kashima H; Maeda N; Kikuchi S; Tazawa H; Shirakawa Y; Fujiwara T
Cancer Immunol Immunother; 2023 Nov; 72(11):3787-3802. PubMed ID: 37668710
[TBL] [Abstract] [Full Text] [Related]
19. Aberrant frequency of TNFR2-expressing CD4+ foxp3+ regulatory T cells in nasopharyngeal carcinoma patients.
Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
[TBL] [Abstract] [Full Text] [Related]
20. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract] [Full Text] [Related]
[Next]
